Global Continuous Glucose Monitoring System Market Report (2017-2023): Companies Profiled Include Medtronic, Dexcom, Abbott, Insulet Corp, Tandem Diabetes & Echo Therapeutics - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Continuous Glucose Monitoring System Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023" report to their offering.

Emergence of continuous glucose monitoring systems is a major breakthrough in the glucose monitoring for diabetic patients. Medtronic and Dexcom are the only major players in this industry followed by Abbott in few regions. Companies are focusing more on research and development before introducing their products in the market. CGMS are highly regulated and go through strict tests before being approved. CGM manufacturers have faced competition from self-monitoring blood glucose devices (SMBG). SMBG devices are cheaper and easy to use and have an less stringent approval process from authorities like FDA. SMBG has more number of players and larger market share.

However, CGM systems have been able to make a good market entry in the U.S. and are following the trend in other territories. CGM system market has seen good growth rates in past three years. Medtronic and Dexcom have introduced new systems which have witnessed lower frequency of errors. The MARD value for new sensors has decreased, new devices need lesser calibrations per day and most of the devices are approved for pediatric use. This has led to 50-60 percent jump in the revenues of some manufacturers.

Companies profiled include

1. Medtronic Inc.

2. Dexcom

3. Abbott

4. Johnson And Johnson (Animas Corp)

5. Insulet Corp

6. Tandem Diabetes

7. Echo Therapeutics

This Research Report covers

1. Historical data

2. Revenue forecasts, growth rates and CAGR up to 2022

3. Industry Analysis

4. Competitive Analysis

5. Key geographic growth data

6. Deep profiles top competitive companies

Key Topics Covered:

Chap 1. Executive Summary

Chap 2. Market Overview

Chap 3. Market Determinants

Chap 4. Sector Analysis: Diabetes Care

Chap 5. CGMS Market By devices

Chap 6. By Application

Chap 7. Competitive Intelligence

Chap 8. Market Share Analysis

Chap 9. Geographical Analysis

Chap 10. Corporate Profile: Benchmark Study

For more information about this report visit http://www.researchandmarkets.com/research/lslh6d/global_continuous

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Glucose Testing, Diabetes Devices, Wearable Technology

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Glucose Testing, Diabetes Devices, Wearable Technology